𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Binding of liver derived, low density hepatitis C virus to human hepatoma cells

✍ Scribed by Caroline Martin; Soren U. Nielsen; Siti Ibrahim; Margaret F. Bassendine; Geoffrey L. Toms


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
134 KB
Volume
80
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

HCV recovered from low density fractions of infected blood is associated with lipid and host apo‐lipoproteins in lipo‐viro‐particles (LVP). It has been proposed that these particles are capable of binding and entering hepatocytes by viral glycoprotein independent mechanisms utilizing uptake pathways of normal host lipoproteins after binding to cell surface glycosaminoglycans (GAG), the low density lipoprotein receptor (LDL‐r) or scavenger receptor B1 (SR‐B1). In this study binding to human hepatoma cells of HCV low density RNA containing particles, semi‐purified from macerates of infected human liver, is compared with that of normal host low density lipoprotein (LDL). Binding of both LDL and HCV low density RNA containing particles paralleled LDL‐r but not SR‐B1 expression on the recipient cells. Binding of both particle types was sensitive to suramin at 0°C but less so at 37°C suggesting that they both bind initially to GAG but, at 37°C, are internalized or transferred to a suramin resistant receptor. Suramin resistant uptake of both particles was blocked in the presence of excess LDL or oxidized LDL. However, whilst LDL uptake was blocked by anti‐apoB‐100, HCV low density RNA uptake was enhanced by anti‐apoB100 and further enhanced by a cocktail of anti‐apo‐B100 and anti‐apoE. Pre‐incubation of HCV low density RNA containing particles with antibodies to the E2 glycoprotein had little or no effect on uptake. These data indicate that whilst liver derived HCV RNA containing particles are taken up by HepG2 cells by a virus glycoprotein independent mechanism, the mechanism differs from that of LDL uptake. J. Med. Virol. 80:816–823, 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Suramin blocks hepatitis C binding to hu
✍ Garson, J.A.; Lubach, D.; Passas, J.; Whitby, K.; Grant, P.R. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

It was demonstrated recently that the binding of dengue virus to its target cell receptor could be effectively blocked by both heparin and by the polysulphonate pharmaceutical, Suramin [Chen et al. (1997) Nature Medicine 3:866-871]. Because both dengue and hepatitis C virus (HCV) belong to the Flavi

Transfection of a rat hepatoma cell line
✍ Zuo Jiong Gong; Sandra De Meyer; Jos van Pelt; Kurt Hertogs; Erik Depla; Ann Sou 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Previously, we have found that human liver annexin V (hA-V; in earlier reports referred as Endonexin II) is a specific hepatitis B surface antigen (HBsAg) binding protein. In this study, we demonstrate that transfection of rat hepatoma FTO 2B cells, a cell line that is not infectable by hepatitis B

A highly hydrophobic domain within hyper
✍ Chie Kurihara; Yoshikazu Tsuzuki; Ryota Hokari; Hiroyuki Nakashima; Norikazu Mat 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract Interaction of the envelope glycoprotein of hepatitis C virus (HCV) with a cellular receptor(s) is thought to be essential for the initial steps of HCV infection. However, the mechanisms of HCV infection remain unclear. The aim of the present study was to determine the features of HCV t

Identification of a protein isolated fro
✍ Bill S. Sun; Xianhua Zhu; Marcy M. Clayton; Jingbo Pan; Mark A. Feitelson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

Hepatitis B virus-encoded X antigen contributes to the development of hepatocellular carcinoma. Given that X antigen functions by binding to other proteins, additional X-binding proteins were sought from an adult human liver cDNA library in a yeast two-hybrid system. The results yielded a clone enco